Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Receivables - Net: 2021

Historic Receivables - Net for Nurix Therapeutics (NRIX) over the last 1 years, with Nov 2021 value amounting to $6.0 million.

  • Nurix Therapeutics' Receivables - Net was N/A to $19.0 million in Q2 2025 from the same period last year, while for May 2025 it was $19.0 million, marking a year-over-year change of. This contributed to the annual value of $6.0 million for FY2021, which is N/A change from last year.
  • According to the latest figures from FY2021, Nurix Therapeutics' Receivables - Net is $6.0 million.
  • Nurix Therapeutics' Receivables - Net's 5-year high stood at $6.0 million during FY2021, with a 5-year trough of $6.0 million in FY2021.
  • Moreover, its 1-year median value for Receivables - Net was $6.0 million (2021), whereas its average is $6.0 million.